The USFDA issued a warning to Indore-based Alpha Arogya for offering ‘unapproved’ and ‘misbranded’ products claiming to prevent and cure coronavirus. With this, Alpha Arogya has become the second Indian company -- after Karnataka-based Homeomart Indibuy -- to receive a warning from USFDA for flouting norms.